STOCK TITAN

Day One Biopharmaceuticals, Inc. (DAWN) Revenue by Year

DAWN

Day One Biopharmaceuticals, Inc. generated $158.2M in revenue in fiscal year 2025. This represents an increase of 20.6% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Day One Biopharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $158.2M
YoY +20.6%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DAWN Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K/AFY2010-KFY1910-K
Revenue$158.2M+20.6%$131.2M$0$0N/AN/AN/A

DAWN Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Revenue$53.7M$39.8M-57.6%$33.9M+313.9%$30.8MN/A$93.8M$8.2M$0N/A$0N/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Day One Biopharmaceuticals, Inc. financials

Frequently Asked Questions

What was Day One Biopharmaceuticals, Inc.'s revenue in fiscal year 2025?

Day One Biopharmaceuticals, Inc. generated $158.2M in revenue in fiscal year 2025.

How fast is Day One Biopharmaceuticals, Inc.'s revenue growing?

Day One Biopharmaceuticals, Inc. (DAWN) revenue rose by 20.6% year over year, from $131.2M to $158.2M in fiscal year 2025.

What was Day One Biopharmaceuticals, Inc.'s revenue in the most recent quarter?

Day One Biopharmaceuticals, Inc. (DAWN) reported $53.7M in revenue in Q4 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Day One Biopharmaceuticals, Inc. (DAWN) reported on that line in every period on record.